Akzo Nobel sells drugs unit to Schering-Plough for 11 bln euros
620527
Dutch-Swedish pharmaceutical group Akzo Nobel said on Monday that it had agreed to sell its Organon BioSciences drugs unit to US rival Schering-Plough for 11 billion euros (14.4 billion dollars).
513568
One Equity Partners agreed to sell its stake in Quintiles Transnational, a big manager of clinical drug trials, to its C.E.O. and two buyout firms.
532352
Dutch-Swedish chemical and pharmaceutical group Akzo Nobel reported on Tuesday &quot;solid&quot; results for the second quarter with a 34-percent rise in net profit for its core division coatings and chemicals.
26608
German and Swiss drug makers Schering and Novartis are developing a new anti-cancer drug with annual sales potential of up to two billion euros (2.7 billion dollars), Schering chief Hubertus Erlen said.
737950
Bayer BAYG.DE had completed its  acquisition of Roche Holding's ROG.VX consumer drugs unit,  the German chemical and drugs group said on Saturday.
238458
Seeking to improve its drug discovery technology and establish a beachhead in the fertile Cambridge biotechnology cluster, drug giant Schering-Plough Corp. of Kenilworth, N.J., said it would buy NeoGenesis Pharmaceuticals Inc. of Cambridge for an undisclosed sum.
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
703946
Akzo Nobel NV on Friday won EU approval for its $17.1 billion acquisition of Imperial Chemicals Industries PLC, but it must sell off Britain's Crown Paints and an adhesive business to clear antitrust concerns.
171103
Biotechnology giant Amgen is selling the Japanese rights to some drugs to Takeda Pharmaceutical of Japan in a deal that might bring Amgen more than $1 billion.
207285
Pfizer Inc. PFE.N has signed a deal  with Schering AG SCHG.DE granting it a worldwide license to  Schering's ADP receptor antagonist program, the U.S. drug maker  said on Wednesday.
541389
BOSTON, Aug. 29 -- Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.
221563
UCB, a Belgian drug maker, said it had agreed to buy Schwarz Pharma of Germany for 4.4 billion euros ($5.6 billion) to gain experimental medicines for ParkinsonÂs disease, epilepsy and bladder control. Schwarz investors will get 91.10 euros a share in cash and stock, 20 percent more than the closing price on Friday, UCB said. The Schwarz-Schuette family, which owns 60 percent of the company, backed the offer. Schwarz, based in Monheim, Germany, is the third European family-owned drug maker to sell in less than a week as the cost of developing new products rises. UCB, which faces patent expirations on its top sellers starting next year, will get three drugs that may provide more than 2 billion euros in annual revenue.
160808
Akzo Nobel  said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough  for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offer.
556480
Priceline has been sold to Australian Pharmaceutical Industries for $112 million in cash and shares just six months after the health and beauty care chain was bought by local managers from its South African parent.
613574
German drug firm Schwarz Pharma is being bought in a 4.4bn euro deal, the third industry tie-up in recent days.
119312
Akzo Nobel said on Monday it was selling its pharmaceuticals unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offer.
170214
BERLIN - Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private US investment groups Cerberus Capital Management and Ampersand Ventures.